Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide, Mannitol and NAC for Cisplatin Nephrotoxicity
NCT02760901Phase 2Completed
- Sponsor
- Ain Shams University
- Start
- Nov 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of acetazolamide, acetylcysteine in cisplatin-induced nephrotoxicity (CIN), sponsored by Ain Shams University. Started Nov 2013; status: completed.
02
Drugs
acetazolamideacetylcysteine
03
Conditions
cisplatin-induced nephrotoxicity (CIN)
Beyond the preview
Go deeper on NCT02760901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02760901.